News

Hisense Large-Screen Displays Elevate Gaming to New Heights at IFA 2024

DUBAI, United Arab Emirates, Sept. 9, 2024 /PRNewswire/ -- Hisense, a global leader in home appliances and consumer electronics, has…

1 year ago

Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024

i-CREATe & WRRC 2024 SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Siyi Intelligence (Syrebo) played a prominent role at the International…

1 year ago

NeoImmuneTech Presents Promising Interim Results of CAR-T Combination with its NT-I7 Asset at ESMO 2024

Adequate cell expansion and persistence remains a key challenge that limits the efficacy of chimeric antigen receptor T (CAR-T) cell therapiesNew…

1 year ago

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

SHENZHEN, China, Sept. 9, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and…

1 year ago

Ping An Selected for Hang Seng Corporate Sustainability Index. Series for 14th Consecutive Year

HONG KONG and SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An",…

1 year ago

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve…

1 year ago

iZafe Group AB and Randstad Partner in Norway to Transform Medication Management and Drive Cost Savings for Municipalities

STOCKHOLM, SE / ACCESSWIRE / September 09, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") today announces a…

1 year ago

Hemogenyx Pharmaceuticals PLC – FLT3 Assay Ready for Phase I Trials at MD Anderson

LONDON, UNITED KINGDOM / ACCESSWIRE / September 9, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on…

1 year ago

 MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand Finals Competition

Medical device company developing solutions for voice and speech disorders is awarded Grand Prize of USD 175,000 at the 6th…

1 year ago

Cantargia: New Data from Two Clinical Studies Strongly Support Nadunolimab Efficacy After Relapse on PD1-Inhibitors

LUND, SE / ACCESSWIRE / September 8, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported data from…

1 year ago